Certificate of Analysis
| Product Name: | Rovalpituzumab-MMAE |
| Catalog Number: | M59308 |
Physical and Chemical Properties
| Form: | Solution |
| Solubility: | For powder, reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. |
| Storage: | Store at ≤ -20℃ for 24 months. Avoid repeated freeze-thaw cycles. |
Product Information
| Description: | Rovalpituzumab-MMAE is an antibody-drug conjugate (ADC) targeting DLL3. Rovalpituzumab is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab has activity against small cell lung cancer (SCLC). |
| Stability and Solubility Advice: | Information concerning product stability, particularly in solution, has rarely been reported and in most cases we can only offer a general guide. We recommend that stock solutions, once prepared, are stored aliquoted in tightly sealed vials and used within 1 month. Avoid repeated freeze and thaw cycles. Storage conditions for some special products should refer to their storage details. |